Table 1.
Demographic and physical characteristics of women with fibromyalgia and healthy women.
| Cases (n = 80) | Controls (n = 80) | p value | ||
|---|---|---|---|---|
| Age (years) | 56.11 ± 7.93 | 57.34 ± 9.72 | 0.384 | |
| Height (cm) | 159.14 ± 5.64 | 158.34 ± 6.35 | 0.401 | |
| Weight (kg) | 71.28 ± 11.06 | 69.18 ± 9.40 | 0.198 | |
| BMI (kg/m2) | 28.69 ± 5.91 | 27.66 ± 3.95 | 0.200 | |
| VAS (mm) | 73.25 ± 18.54 | 19.49 ± 26.06 | <0.001* | |
| FIQ-R | ||||
| FIQ-R.1 | 19.92 ± 5.71 | – | – | |
| FIQ-R.2 | 13.69 ± 5.11 | – | – | |
| FIQ-R.3 | 37.35 ± 8.89 | – | – | |
| Total score | 70.95 ± 16.65 | – | – | |
| CSS | 67.73 ± 11.58 | 27.99 ± 15.45 | <0.001* | |
| Sleep Questionnaire Index global score | 15.21 ± 3.82 | 7.06 ± 4.79 | <0.001* | |
| Fatigue | ||||
| MFI general fatigue | 18.16 ± 2.36 | 10.10 ± 4.64 | <0.001* | |
| MFI physical fatigue | 16.69 ± 2.81 | 9.71 ± 4.61 | <0.001* | |
| MFI mental fatigue | 15.16 ± 1.72 | 11.94 ± 3.14 | <0.001* | |
| MFI reduced activity | 15.29 ± 3.72 | 8.15 ± 4.24 | <0.001* | |
| MFI reduced motivation | 14.31 ± 3.34 | 7.61 ± 3.54 | <0.001* | |
| Anxiety | 32.14 ± 9.86 | 11.96 ± 10.99 | <0.001* | |
| Hypothenar eminence temperature (°C) | 32.71 ± 1.33 | 30.95 ± 1.78 | <0.001* | |
| Tympanic temperature (°C) | 35.96 ± 0.66 | 35.77 ± 0.67 | 0.071 | |
| Pain pressure thresholds | ||||
| Occipital | D | 0.96 ± 0.72 | 3.28 ± 1.38 | <0.001* |
| ND | 0.89 ± 0.68 | 3.09 ± 1.28 | <0.001* | |
| Cervical Low | D | 1.11 ± 0.76 | 3.07 ± 1.82 | <0.001* |
| ND | 1.06 ± 0.77 | 3.11 ± 2.06 | <0.001* | |
| Trapezium | D | 1.03 ± 0.72 | 3.09 ± 1.41 | <0.001* |
| ND | 0.99 ± 0.62 | 3.32 ± 1.73 | <0.001* | |
| Supraspinatus | D | 1.27 ± 0.80 | 3.61 ± 1.93 | <0.001* |
| ND | 1.27 ± 0.73 | 3.57 ± 1.89 | <0.001* | |
| Second rib | D | 0.91 ± 0.48 | 2.40 ± 1.28 | <0.001* |
| ND | 0.87 ± 0.47 | 2.49 ± 1.16 | <0.001* | |
| Epicondyle | D | 0.97 ± 0.60 | 3.18 ± 1.46 | <0.001* |
| ND | 0.99 ± 0.58 | 3.35 ± 1.50 | <0.001* | |
| Second metacarpal | D | 1.23 ± 0.79 | 3.16 ± 1.47 | <0.001* |
| ND | 1.18 ± 0.66 | 3.22 ± 1.79 | <0.001* | |
| Gluteal muscle | D | 1.99 ± 1.57 | 6.20 ± 2.59 | <0.001* |
| ND | 1.89 ± 1.27 | 6.13 ± 2.48 | <0.001* | |
| Greater trochanter | D | 2.09 ± 1.19 | 5.91 ± 2.40 | <0.001* |
| ND | 2.09 ± 1.12 | 5.48 ± 2.39 | <0.001* | |
| Knee | D | 1.70 ± 1.24 | 5.41 ± 2.31 | <0.001* |
| ND | 1.86 ± 1.22 | 5.70 ± 2.49 | <0.001* | |
| Anterior tibial | D | 1.86 ± 1.40 | 5.09 ± 2.47 | <0.001* |
| ND | 1.82 ± 1.18 | 5.04 ± 2.37 | <0.001* | |
Data are expressed as mean ± SD.
*
Statistically significant.
Significance level p < 0.05.
BMI, body mass index; CSS, central sensitization syndrome; D, dominant; FIQ-R, revised Fibromyalgia Impact Questionnaire; FIQ-R.1, activity level of the FIQ; FIQ-R.2, overall impact of the FIQ-R; FIQ-R.3, intensity of symptoms of the FIQ-R; MFI, Multidimensional Fatigue Inventory; ND, non-dominant; SD, standard deviation; VAS, visual analogue scale.